Index RUT
P/E -
EPS (ttm) -1.21
Insider Own 6.08%
Shs Outstand 267.74M
Perf Week 24.49%
Market Cap 498.38M
Forward P/E -
EPS next Y -0.82
Insider Trans -1.21%
Shs Float 255.79M
Perf Month -45.05%
Income -306.74M
PEG -
EPS next Q -0.28
Inst Own 97.75%
Short Float 18.97%
Perf Quarter -72.89%
Sales 200.42M
P/S 2.49
EPS this Y 15.59%
Inst Trans -6.30%
Short Ratio 4.83
Perf Half Y -69.35%
Book/sh 2.62
P/B 0.70
EPS next Y 19.52%
ROA -17.46%
Short Interest 48.52M
Perf Year -84.43%
Cash/sh 2.32
P/C 0.79
EPS next 5Y -1.00%
ROE -48.53%
52W Range 1.25 - 14.55
Perf YTD -81.35%
Dividend Est. -
P/FCF -
EPS past 5Y -9.76%
ROI -18.87%
52W High -87.42%
Beta 2.00
Dividend TTM -
Quick Ratio 7.21
Sales past 5Y 24.48%
Gross Margin 20.12%
52W Low 46.40%
ATR (14) 0.28
Dividend Ex-Date -
Current Ratio 7.81
EPS Y/Y TTM 13.38%
Oper. Margin -154.86%
RSI (14) 35.10
Volatility 13.90% 13.55%
Employees 796
Debt/Eq 1.33
Sales Y/Y TTM 49.53%
Profit Margin -153.05%
Recom 2.21
Target Price 4.82
Option/Short Yes / Yes
LT Debt/Eq 1.32
EPS Q/Q -
Payout -
Rel Volume 1.44
Prev Close 1.76
Sales Surprise 1.54%
EPS Surprise -8.05%
Sales Q/Q -0.26%
Earnings May 09 AMC
Avg Volume 10.04M
Price 1.83
SMA20 -14.64%
SMA50 -46.19%
SMA200 -75.64%
Trades
Volume 14,499,788
Change 3.98%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-22-24 Downgrade
JP Morgan
Overweight → Neutral
Apr-18-24 Downgrade
Goldman
Buy → Neutral
$7 → $2.50
Dec-14-23 Initiated
Stephens
Overweight
$11
Dec-14-23 Initiated
Guggenheim
Neutral
Dec-13-23 Initiated
Wolfe Research
Peer Perform
Nov-17-23 Upgrade
UBS
Neutral → Buy
$13 → $10
Oct-31-23 Upgrade
Cantor Fitzgerald
Neutral → Overweight
$11
Sep-28-23 Initiated
Bernstein
Outperform
$11
Jul-05-23 Resumed
JP Morgan
Overweight
$13
Jun-30-23 Initiated
Goldman
Buy
$17
May-10-23 Initiated
Barclays
Equal Weight
$14
Mar-31-23 Upgrade
TD Cowen
Market Perform → Outperform
$13 → $15
Feb-02-23 Initiated
UBS
Neutral
$13
Jan-20-23 Downgrade
Cantor Fitzgerald
Overweight → Neutral
$12
Jan-05-23 Initiated
Scotiabank
Sector Outperform
$12
Jan-21-22 Resumed
Cantor Fitzgerald
Overweight
$62 → $31
Jan-06-22 Resumed
Piper Sandler
Neutral
$20
Oct-15-21 Resumed
Cowen
Market Perform
$30
Sep-27-21 Initiated
Canaccord Genuity
Buy
$45
Feb-11-21 Upgrade
Piper Sandler
Neutral → Overweight
$20 → $52
Show Previous Ratings
May-02-24 09:00AM
Apr-25-24 09:35AM
Apr-23-24 12:00PM
Apr-17-24 01:00PM
Apr-16-24 02:47PM
08:05AM
Loading…
08:05AM
Apr-03-24 10:54AM
Mar-27-24 08:00AM
Mar-22-24 04:30PM
Mar-13-24 03:32PM
10:17AM
Mar-12-24 09:05AM
Mar-06-24 11:57PM
Feb-27-24 03:30AM
Feb-26-24 04:05PM
07:04AM
Loading…
Feb-25-24 07:04AM
Feb-22-24 04:21AM
Feb-16-24 10:50AM
08:59AM
08:34AM
(Thomson Reuters StreetEvents)
Feb-15-24 06:30PM
05:30PM
04:43PM
04:28PM
(Associated Press Finance)
04:05PM
Feb-13-24 07:00AM
Feb-10-24 05:09PM
Feb-06-24 09:41AM
Feb-05-24 09:05AM
Jan-25-24 04:03PM
12:13PM
Loading…
Jan-16-24 12:13PM
Jan-15-24 09:05AM
Jan-11-24 10:00AM
Jan-09-24 10:43AM
Jan-08-24 08:00AM
Dec-27-23 04:05PM
Dec-26-23 08:24AM
Dec-20-23 01:50PM
Dec-11-23 08:00AM
Dec-10-23 04:00PM
11:59AM
Nov-10-23 09:30AM
Nov-09-23 04:10PM
Nov-02-23 09:05AM
Nov-01-23 09:05AM
Oct-31-23 11:35AM
09:34AM
09:05AM
Oct-30-23 06:00PM
04:19PM
(Associated Press Finance)
04:03PM
03:46PM
Oct-18-23 05:52AM
Oct-17-23 10:04AM
Oct-16-23 10:43AM
08:05AM
Oct-12-23 04:03PM
Oct-11-23 09:05AM
Oct-06-23 12:11PM
Sep-19-23 12:07PM
Sep-18-23 11:55AM
Sep-14-23 12:56PM
12:32PM
07:30AM
Sep-13-23 12:48PM
(Investor's Business Daily) +8.92%
Sep-12-23 08:00AM
Sep-08-23 07:23AM
Sep-07-23 09:05AM
Sep-05-23 12:25PM
09:52AM
Aug-09-23 04:03PM
10:00AM
08:16AM
Aug-07-23 09:18AM
08:00AM
Aug-04-23 07:20PM
08:30AM
Aug-03-23 01:16PM
Aug-02-23 06:15PM
05:06PM
04:06PM
04:04PM
04:02PM
Jul-26-23 10:02AM
Jul-19-23 04:05PM
Jul-07-23 12:04PM
Jul-05-23 10:30AM
Jun-30-23 10:27AM
09:14AM
Jun-28-23 07:00AM
Jun-26-23 06:00AM
Jun-20-23 11:41AM
Jun-14-23 11:40AM
07:00AM
Jun-02-23 12:08PM
11:31AM
May-30-23 09:05AM
May-25-23 04:03PM
May-04-23 10:05AM
May-03-23 04:05PM
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ORDONEZ KATHY Director Mar 15 '24 Option Exercise 2.87 361,621 1,038,682 380,216 Mar 19 04:24 PM Meline David W Director Mar 06 '24 Buy 4.40 40,000 176,160 40,000 Mar 06 05:36 PM HENRY CHRISTIAN O See Remarks Mar 04 '24 Sale 4.87 14,177 69,056 2,596,670 Mar 06 05:12 PM Van Oene Mark See Remarks Mar 04 '24 Sale 4.87 9,186 44,745 1,668,826 Mar 06 05:26 PM Kim Susan G. See Remarks Mar 04 '24 Sale 4.87 5,275 25,695 712,260 Mar 06 05:22 PM Farmer Michele See Remarks Mar 04 '24 Sale 4.87 2,968 14,457 217,216 Mar 06 05:30 PM MOHR MARSHALL Director Mar 01 '24 Option Exercise 4.45 25,000 111,250 110,000 Mar 05 04:27 PM HENRY CHRISTIAN O See Remarks Feb 20 '24 Sale 5.26 1,979 10,412 1,005,078 Feb 21 06:14 PM Kim Susan G. See Remarks Feb 20 '24 Sale 5.26 831 4,372 282,758 Feb 21 06:17 PM HENRY CHRISTIAN O See Remarks Feb 16 '24 Sale 5.96 79,038 470,908 1,007,057 Feb 21 06:14 PM Van Oene Mark See Remarks Feb 16 '24 Sale 5.96 33,560 199,950 876,611 Feb 21 06:25 PM Kim Susan G. See Remarks Feb 16 '24 Sale 5.96 22,496 134,031 283,589 Feb 21 06:17 PM Eidel Jeff See Remarks Feb 16 '24 Sale 5.96 15,498 92,337 431,824 Feb 21 06:20 PM Farmer Michele See Remarks Feb 16 '24 Sale 5.96 7,562 45,054 101,164 Feb 21 06:07 PM Van Oene Mark See Remarks Jan 09 '24 Sale 7.77 31,012 241,056 910,171 Jan 10 05:44 PM HENRY CHRISTIAN O See Remarks Dec 14 '23 Sale 10.00 20,000 200,000 1,086,095 Dec 15 04:35 PM Kim Susan G. See Remarks Sep 29 '23 Sale 8.44 19,257 162,471 306,085 Sep 29 06:47 PM HENRY CHRISTIAN O See Remarks Sep 18 '23 Sale 10.12 96,844 980,255 1,106,095 Sep 19 04:32 PM HENRY CHRISTIAN O See Remarks Sep 11 '23 Sale 10.45 10,000 104,520 1,202,939 Sep 12 04:42 PM Eidel Jeff See Remarks Aug 17 '23 Sale 10.60 25,936 274,844 444,666 Aug 18 04:36 PM HENRY CHRISTIAN O See Remarks Aug 17 '23 Sale 10.50 10,000 105,000 1,212,939 Aug 18 04:44 PM Van Oene Mark See Remarks Aug 16 '23 Sale 11.00 26,102 287,122 939,769 Aug 18 04:26 PM MOHR MARSHALL Director May 18 '23 Option Exercise 2.54 25,000 63,500 85,000 May 22 04:57 PM Farmer Michele See Remarks May 18 '23 Sale 12.59 5,165 65,027 107,577 May 19 07:10 PM
Index NDX, S&P 500
P/E -
EPS (ttm) -15.68
Insider Own 12.14%
Shs Outstand 382.00M
Perf Week 15.77%
Market Cap 47.86B
Forward P/E -
EPS next Y -5.33
Insider Trans -0.58%
Shs Float 336.41M
Perf Month 22.23%
Income -5968.00M
PEG -
EPS next Q -3.41
Inst Own 67.83%
Short Float 6.24%
Perf Quarter 28.21%
Sales 5.14B
P/S 9.30
EPS this Y 41.17%
Inst Trans 0.89%
Short Ratio 5.35
Perf Half Y 64.04%
Book/sh 33.46
P/B 3.74
EPS next Y 26.55%
ROA -29.22%
Short Interest 20.98M
Perf Year -3.95%
Cash/sh 22.30
P/C 5.60
EPS next 5Y -
ROE -37.68%
52W Range 62.55 - 142.79
Perf YTD 25.69%
Dividend Est. -
P/FCF -
EPS past 5Y -20.02%
ROI -42.54%
52W High -12.46%
Beta 1.50
Dividend TTM -
Quick Ratio 3.91
Sales past 5Y 662.08%
Gross Margin 11.10%
52W Low 99.84%
ATR (14) 5.39
Dividend Ex-Date -
Current Ratio 4.03
EPS Y/Y TTM -227.99%
Oper. Margin -100.04%
RSI (14) 72.77
Volatility 5.51% 4.62%
Employees 5600
Debt/Eq 0.10
Sales Y/Y TTM -65.53%
Profit Margin -116.00%
Recom 2.32
Target Price 134.83
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q -1676.58%
Payout -
Rel Volume 1.13
Prev Close 125.59
Sales Surprise 79.07%
EPS Surprise 13.68%
Sales Q/Q -91.07%
Earnings May 02 BMO
Avg Volume 3.92M
Price 125.00
SMA20 16.40%
SMA50 19.81%
SMA200 26.98%
Trades
Volume 4,451,017
Change -0.47%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Downgrade
HSBC Securities
Hold → Reduce
$75 → $86
Jan-02-24 Upgrade
Oppenheimer
Perform → Outperform
$142
Nov-29-23 Initiated
Canaccord Genuity
Hold
$82
Nov-03-23 Upgrade
HSBC Securities
Reduce → Hold
$89 → $69
Nov-02-23 Downgrade
Deutsche Bank
Hold → Sell
$125 → $60
Aug-04-23 Downgrade
TD Cowen
Outperform → Market Perform
$145 → $125
Aug-03-23 Downgrade
Deutsche Bank
Buy → Hold
$125
Jul-24-23 Initiated
William Blair
Mkt Perform
$136.28
Jul-14-23 Initiated
HSBC Securities
Reduce
$97
Jun-26-23 Upgrade
UBS
Neutral → Buy
$221 → $191
Apr-26-23 Initiated
Guggenheim
Neutral
Mar-13-23 Upgrade
TD Cowen
Market Perform → Outperform
$150 → $180
Mar-02-23 Initiated
RBC Capital Mkts
Outperform
$200
Feb-24-23 Downgrade
SVB Securities
Market Perform → Underperform
$111 → $93
Dec-19-22 Upgrade
Jefferies
Hold → Buy
$170 → $275
Dec-14-22 Downgrade
Chardan Capital Markets
Buy → Neutral
$186 → $191
Oct-21-22 Upgrade
SVB Leerink
Underperform → Mkt Perform
$174 → $101
Sep-08-22 Upgrade
Deutsche Bank
Hold → Buy
$165
Feb-01-22 Upgrade
Redburn
Sell → Neutral
Jan-26-22 Upgrade
Deutsche Bank
Sell → Hold
$175
Show Previous Ratings
Today 10:49AM
06:34AM
01:01AM
May-03-24 08:45AM
08:26AM
08:24AM
Loading…
08:24AM
08:21AM
08:08AM
07:55AM
07:27AM
07:19AM
06:24AM
06:23AM
06:15AM
05:00AM
04:42AM
Loading…
04:42AM
(Pharmaceutical Technology)
03:04AM
May-02-24 06:47PM
(Morningstar Research) +12.68%
06:36PM
05:23PM
05:21PM
04:17PM
04:03PM
(Investor's Business Daily)
03:58PM
03:12PM
02:53PM
02:23PM
01:55PM
01:38PM
12:43PM
12:34PM
Loading…
12:34PM
(Investor's Business Daily)
12:30PM
11:33AM
11:14AM
(The Wall Street Journal)
11:14AM
10:53AM
10:47AM
10:26AM
10:19AM
(The Wall Street Journal)
10:05AM
08:26AM
08:26AM
08:19AM
07:52AM
07:40AM
07:30AM
07:26AM
07:22AM
06:40AM
(Associated Press Finance)
06:33AM
06:30AM
(Investor's Business Daily)
06:30AM
06:30AM
06:30AM
06:00AM
May-01-24 04:57PM
02:38PM
01:53PM
11:07AM
10:05AM
Apr-30-24 03:20PM
02:03PM
Apr-29-24 12:02PM
11:33AM
09:16AM
Apr-27-24 08:06AM
Apr-26-24 06:00PM
05:00AM
05:00AM
04:50AM
Apr-25-24 10:35AM
10:02AM
09:54AM
07:00AM
Apr-24-24 02:49PM
(Investor's Business Daily)
11:36AM
08:24AM
08:00AM
07:00AM
(The Wall Street Journal)
Apr-23-24 07:21AM
Apr-22-24 11:10AM
07:00AM
Apr-19-24 05:50PM
01:26AM
Apr-17-24 06:00PM
01:22PM
07:00AM
Apr-16-24 01:49PM
09:00AM
04:55AM
Apr-14-24 05:55AM
Apr-12-24 08:45AM
05:00AM
Apr-11-24 06:00PM
02:48PM
06:52AM
06:36AM
Apr-10-24 12:47PM
12:10PM
(Investor's Business Daily)
10:59AM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
AFEYAN NOUBAR Director May 01 '24 Sale 110.92 15,000 1,663,855 2,026,931 May 03 07:00 PM AFEYAN NOUBAR Director Apr 24 '24 Sale 108.32 15,000 1,624,836 2,041,931 Apr 26 07:00 PM AFEYAN NOUBAR Director Apr 17 '24 Sale 103.38 15,000 1,550,703 2,056,931 Apr 19 07:00 PM Hoge Stephen President Apr 15 '24 Sale 105.02 15,000 1,575,300 1,486,241 Apr 16 04:23 PM AFEYAN NOUBAR Director Apr 10 '24 Sale 107.12 15,000 1,606,865 2,071,931 Apr 12 07:00 PM Mock James M Chief Financial Officer Apr 08 '24 Sale 101.93 705 71,859 5,048 Apr 09 04:09 PM AFEYAN NOUBAR Director Apr 03 '24 Sale 101.68 15,000 1,525,268 2,086,931 Apr 05 07:00 PM AFEYAN NOUBAR Director Mar 27 '24 Sale 109.06 15,000 1,635,864 2,101,931 Mar 29 07:00 PM AFEYAN NOUBAR Director Mar 20 '24 Sale 102.39 15,000 1,535,820 2,116,931 Mar 22 07:00 PM Hoge Stephen President Mar 15 '24 Sale 103.17 15,000 1,547,550 1,501,241 Mar 19 04:39 PM AFEYAN NOUBAR Director Mar 13 '24 Sale 108.54 15,000 1,628,031 2,131,931 Mar 15 07:00 PM Klinger Shannon Thyme Chief Legal Officer Mar 08 '24 Sale 99.05 544 53,884 9,267 Mar 11 09:05 AM Hoge Stephen President Mar 04 '24 Sale 94.34 309 29,151 1,516,241 Mar 05 05:52 PM Klinger Shannon Thyme Chief Legal Officer Mar 04 '24 Sale 94.34 117 11,038 8,673 Mar 05 05:56 PM Hoge Stephen President Feb 29 '24 Sale 94.57 2,388 225,838 1,515,898 Mar 01 05:25 PM Klinger Shannon Thyme Chief Legal Officer Feb 29 '24 Sale 94.57 670 63,363 8,557 Mar 01 05:29 PM Mock James M Chief Financial Officer Feb 29 '24 Sale 94.57 647 61,188 4,300 Mar 01 05:33 PM Hoge Stephen President Feb 22 '24 Sale 100.00 15,000 1,500,000 1,513,433 Feb 23 04:04 PM Bancel Stephane Chief Executive Officer Feb 16 '24 Sale 88.88 26,351 2,342,098 5,460,224 Feb 16 04:10 PM Hoge Stephen President Feb 16 '24 Sale 88.88 10,542 936,981 1,528,433 Feb 16 04:19 PM Hoge Stephen President Feb 12 '24 Sale 86.23 304 26,214 1,516,281 Feb 13 04:13 PM Hoge Stephen President Jan 16 '24 Sale 103.90 15,000 1,558,500 1,516,063 Jan 17 04:12 PM Mock James M Chief Financial Officer Jan 08 '24 Sale 109.75 772 84,731 3,632 Jan 09 04:08 PM Hoge Stephen President Dec 27 '23 Sale 100.01 45,000 4,500,450 1,531,063 Dec 28 08:00 AM Klinger Shannon Thyme Chief Legal Officer Dec 08 '23 Sale 79.09 563 44,525 7,912 Dec 11 04:03 PM Garay Arpa Chief Commercial Officer Dec 06 '23 Sale 78.34 564 44,182 3,690 Dec 07 04:21 PM Hoge Stephen President Dec 04 '23 Sale 79.31 309 24,508 1,576,063 Dec 05 04:07 PM Klinger Shannon Thyme Chief Legal Officer Dec 04 '23 Sale 79.31 111 8,804 7,336 Dec 05 04:10 PM Hoge Stephen President Nov 29 '23 Sale 79.81 1,136 90,666 1,575,721 Nov 30 04:11 PM Hoge Stephen President Nov 10 '23 Sale 68.76 263 18,084 1,574,446 Nov 13 04:02 PM AFEYAN NOUBAR Director Nov 01 '23 Sale 76.00 10,000 760,032 2,146,931 Nov 03 07:00 PM AFEYAN NOUBAR Director Oct 25 '23 Sale 76.99 10,000 769,854 2,156,931 Oct 27 07:00 PM AFEYAN NOUBAR Director Oct 11 '23 Sale 103.30 15,000 1,549,441 2,166,931 Oct 13 07:00 PM Mock James M Chief Financial Officer Oct 06 '23 Sale 102.50 2,858 292,953 2,952 Oct 10 04:51 PM AFEYAN NOUBAR Director Oct 04 '23 Sale 102.72 15,000 1,540,845 2,181,931 Oct 06 07:02 PM AFEYAN NOUBAR Director Sep 27 '23 Sale 98.96 10,000 989,646 2,196,931 Sep 29 07:00 PM AFEYAN NOUBAR Director Sep 20 '23 Sale 104.74 15,000 1,571,090 2,206,931 Sep 22 07:00 PM Hoge Stephen President Sep 15 '23 Sale 112.99 15,000 1,694,850 1,574,187 Sep 18 04:06 PM AFEYAN NOUBAR Director Sep 13 '23 Sale 109.70 15,000 1,645,522 2,221,931 Sep 15 07:00 PM Klinger Shannon Thyme Chief Legal Officer Sep 08 '23 Sale 107.22 557 59,722 7,215 Sep 11 04:02 PM AFEYAN NOUBAR Director Sep 06 '23 Sale 107.61 15,000 1,614,094 1,982,209 Sep 08 07:01 PM Garay Arpa Chief Commercial Officer Sep 06 '23 Sale 108.40 574 62,219 3,113 Sep 07 04:46 PM Hoge Stephen President Sep 05 '23 Sale 111.44 320 35,660 1,589,187 Sep 06 04:08 PM Klinger Shannon Thyme Chief Legal Officer Sep 05 '23 Sale 111.44 115 12,815 6,634 Sep 06 04:17 PM AFEYAN NOUBAR Director Aug 30 '23 Sale 115.46 15,000 1,731,951 1,997,209 Sep 01 07:00 PM Hoge Stephen President Aug 29 '23 Sale 115.01 1,135 130,542 1,588,855 Aug 30 04:07 PM AFEYAN NOUBAR Director Aug 23 '23 Sale 115.51 15,000 1,732,613 2,012,209 Aug 25 07:00 PM Hoge Stephen President Aug 17 '23 Sale 100.00 15,000 1,500,000 1,587,579 Aug 18 05:16 PM AFEYAN NOUBAR Director Aug 16 '23 Sale 97.56 10,000 975,614 2,027,209 Aug 18 07:01 PM Hoge Stephen President Aug 10 '23 Sale 102.53 247 25,325 1,602,579 Aug 11 04:18 PM AFEYAN NOUBAR Director Aug 02 '23 Sale 110.99 15,000 1,664,876 2,037,209 Aug 04 07:00 PM AFEYAN NOUBAR Director Jul 26 '23 Sale 120.42 15,000 1,806,229 2,052,209 Jul 28 07:05 PM AFEYAN NOUBAR Director Jul 19 '23 Sale 125.48 15,000 1,882,152 2,067,209 Jul 21 07:00 PM Hoge Stephen President Jul 17 '23 Sale 120.60 15,000 1,809,000 1,602,303 Jul 18 04:35 PM AFEYAN NOUBAR Director Jul 12 '23 Sale 125.81 15,000 1,887,081 2,082,209 Jul 14 07:01 PM AFEYAN NOUBAR Director Jul 05 '23 Sale 124.73 15,000 1,870,933 2,097,209 Jul 07 07:00 PM Bancel Stephane Chief Executive Officer Jun 28 '23 Option Exercise 0.99 27,155 26,883 5,439,101 Jun 30 04:51 PM Bancel Stephane Chief Executive Officer Jun 28 '23 Sale 121.63 27,155 3,302,907 5,411,946 Jun 30 04:51 PM AFEYAN NOUBAR Director Jun 28 '23 Sale 121.54 15,000 1,823,160 2,112,209 Jun 30 07:02 PM Bancel Stephane Chief Executive Officer Jun 22 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 23 04:03 PM Bancel Stephane Chief Executive Officer Jun 22 '23 Sale 119.41 40,000 4,776,427 5,411,946 Jun 23 04:03 PM Bancel Stephane Chief Executive Officer Jun 21 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 23 04:03 PM Bancel Stephane Chief Executive Officer Jun 21 '23 Sale 121.98 40,000 4,879,287 5,411,946 Jun 23 04:03 PM AFEYAN NOUBAR Director Jun 21 '23 Sale 121.95 15,000 1,829,227 2,127,209 Jun 23 07:01 PM Bancel Stephane Chief Executive Officer Jun 15 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 16 04:15 PM Bancel Stephane Chief Executive Officer Jun 15 '23 Sale 128.41 40,000 5,136,388 5,411,946 Jun 16 04:15 PM Hoge Stephen President Jun 15 '23 Sale 125.93 15,000 1,888,950 1,617,303 Jun 16 04:10 PM Bancel Stephane Chief Executive Officer Jun 14 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 16 04:15 PM Bancel Stephane Chief Executive Officer Jun 14 '23 Sale 126.14 40,000 5,045,486 5,411,946 Jun 16 04:15 PM AFEYAN NOUBAR Director Jun 14 '23 Sale 126.18 15,000 1,892,627 2,142,209 Jun 16 07:00 PM Bancel Stephane Chief Executive Officer Jun 08 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 09 04:14 PM Bancel Stephane Chief Executive Officer Jun 08 '23 Sale 124.01 40,000 4,960,364 5,411,946 Jun 09 04:14 PM Klinger Shannon Thyme Chief Legal Officer Jun 08 '23 Sale 124.09 565 70,111 6,516 Jun 09 04:09 PM Bancel Stephane Chief Executive Officer Jun 07 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 09 04:14 PM Bancel Stephane Chief Executive Officer Jun 07 '23 Sale 125.81 40,000 5,032,420 5,411,946 Jun 09 04:14 PM AFEYAN NOUBAR Director Jun 07 '23 Sale 125.91 15,000 1,888,601 2,157,209 Jun 09 07:00 PM Garay Arpa Chief Commercial Officer Jun 06 '23 Sale 125.75 2,290 287,972 2,547 Jun 07 04:05 PM Hoge Stephen President Jun 02 '23 Sale 130.32 309 40,270 1,632,303 Jun 05 04:16 PM Klinger Shannon Thyme Chief Legal Officer Jun 02 '23 Sale 130.32 110 14,336 5,942 Jun 05 04:20 PM Bancel Stephane Chief Executive Officer Jun 01 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer Jun 01 '23 Sale 127.96 40,000 5,118,473 5,411,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer May 31 '23 Option Exercise 0.99 40,000 39,600 5,451,946 Jun 02 04:46 PM Bancel Stephane Chief Executive Officer May 31 '23 Sale 126.91 40,000 5,076,558 5,411,946 Jun 02 04:46 PM AFEYAN NOUBAR Director May 31 '23 Sale 127.35 15,000 1,910,322 2,172,209 Jun 02 07:00 PM Hoge Stephen President May 30 '23 Sale 124.95 1,181 147,569 1,631,961 May 31 04:21 PM Bancel Stephane Chief Executive Officer May 25 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 25 '23 Sale 127.36 40,000 5,094,421 5,411,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 24 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 24 '23 Sale 131.43 40,000 5,257,212 5,411,946 May 26 04:59 PM Bancel Stephane Chief Executive Officer May 18 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 18 '23 Sale 123.77 40,000 4,950,999 5,411,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 17 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 17 '23 Sale 125.32 40,000 5,012,648 5,411,946 May 19 04:12 PM Bancel Stephane Chief Executive Officer May 11 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 11 '23 Sale 127.26 40,000 5,090,486 5,411,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 10 '23 Option Exercise 0.99 40,000 39,600 5,451,946 May 12 04:08 PM Bancel Stephane Chief Executive Officer May 10 '23 Sale 131.60 40,000 5,264,032 5,411,946 May 12 04:08 PM Hoge Stephen President May 10 '23 Sale 133.37 250 33,344 1,630,732 May 11 04:09 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite